Correlation Between Disney and Revance Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Disney and Revance Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Disney and Revance Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walt Disney and Revance Therapeutics,, you can compare the effects of market volatilities on Disney and Revance Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Disney with a short position of Revance Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Disney and Revance Therapeutics,.
Diversification Opportunities for Disney and Revance Therapeutics,
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Disney and Revance is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Walt Disney and Revance Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revance Therapeutics, and Disney is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walt Disney are associated (or correlated) with Revance Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revance Therapeutics, has no effect on the direction of Disney i.e., Disney and Revance Therapeutics, go up and down completely randomly.
Pair Corralation between Disney and Revance Therapeutics,
Considering the 90-day investment horizon Walt Disney is expected to under-perform the Revance Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Walt Disney is 2.45 times less risky than Revance Therapeutics,. The stock trades about -0.13 of its potential returns per unit of risk. The Revance Therapeutics, is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 306.00 in Revance Therapeutics, on December 28, 2024 and sell it today you would earn a total of 59.00 from holding Revance Therapeutics, or generate 19.28% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 44.26% |
Values | Daily Returns |
Walt Disney vs. Revance Therapeutics,
Performance |
Timeline |
Walt Disney |
Revance Therapeutics, |
Risk-Adjusted Performance
Good
Weak | Strong |
Disney and Revance Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Disney and Revance Therapeutics,
The main advantage of trading using opposite Disney and Revance Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Disney position performs unexpectedly, Revance Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revance Therapeutics, will offset losses from the drop in Revance Therapeutics,'s long position.Disney vs. Roku Inc | Disney vs. AMC Entertainment Holdings | Disney vs. Paramount Global Class | Disney vs. Warner Bros Discovery |
Revance Therapeutics, vs. DiaMedica Therapeutics | Revance Therapeutics, vs. Akero Therapeutics | Revance Therapeutics, vs. Nuvalent | Revance Therapeutics, vs. Immunocore Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |